Okyo Pharma Share Price. OKYO - Stock Quote, Charts, Trade History, Share Chat, Financials. Okyo Pharma Limited

Gold vs US Dollar

Home
Investing
Stocks
UK
LSE
Okyo Pharma Limited (OKYO)
Okyo Pharma Limited (OKYO) Share Price

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Okyo Pharma Limited	LSE:OKYO	London	Ordinary Share	GG00BD3FV870	ORD NPV

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	91.00	0.00	01:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
1.20		1.60

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Miscellaneous Metal Ores,nec	0.00	-3.98	-0.30	-	1,287.69

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
-	O	0	91.00	GBX

Related Shares
Bhp (BHP), Rio Tinto (RIO), Shefa Gems (SEFA), Pembridge Resources (PERE)

Okyo Pharma (OKYO) Latest News

Okyo Pharma News

Date	Time	Source	Headline
22/5/2023	08:15	UKREG	OKYO Pharma Limited London Stock Exchange Delisting
22/5/2023	08:00	UKREG	London Stock Exchange Notice Cancellation - OKYO PHARMA LIMITED
19/5/2023	11:22	ALNC	IN BRIEF: Okyo Pharma to move shares to New York with London delisting
19/5/2023	08:00	RNSNON	OKYO Pharma Limited ADS Program collapse
15/5/2023	07:00	UKREG	OKYO Pharma Limited Change of Record Time and Last Day of Dealings
11/5/2023	14:27	ALNC	IN BRIEF: Okyo Pharma delays delisting from London trading to May 22
11/5/2023	12:00	RNSNON	OKYO Pharma Limited Webull Corporate Communications Service Platform
11/5/2023	07:00	UKREG	OKYO Pharma Limited Change of Delisting Date to 22 May 2023
03/5/2023	13:00	UKREG	OKYO Pharma Limited Result of Meeting
03/5/2023	07:00	RNSNON	OKYO Pharma Limited Presentation on OK-101 at ASCRS

More Okyo Pharma News

Okyo Pharma Investors Okyo Pharma Takeover Rumours

Okyo Pharma (OKYO) Discussions and Chat

Okyo Pharma Forums and Chat

Date	Time	Title	Posts
18/4/2023	18:03	OKYO Pharma PLC	692
17/4/2019	05:44	(OKYO) OKYO Pharma Says Data Shows Potential Of Its Dry Eye Treatment	6
17/4/2019	05:44	OKYO PHARMA (OKYO)	14

Add a New Thread

Okyo Pharma (OKYO) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Okyo Pharma trades in real-time

Okyo Pharma (OKYO) Top Chat Posts

Top Posts
Posted at 04/4/2023 21:19 by faraweigh2 On NASDAQ maybe tick thwat?NASDAQ will underpin Market Cap and OKYO will indeed go stratospheric. Hardly rocket science ffs.Doh Read Full Thread Follow Reply
Posted at 04/4/2023 15:31 by faraweigh2 lol!!Read the RNS detail as all is quite clear.Onwards and upwards is the way for the Market Cap here at Okyo. Fact. Read Full Thread Follow Reply
Posted at 04/4/2023 08:08 by babbler Not a surprise. UK investors don't get OKYO. Read Full Thread Follow Reply
Posted at 03/4/2023 13:37 by jimduggen They will have to take the share price up here soon. Nasdaq stock is going up 10% a day Read Full Thread Follow Reply
Posted at 01/4/2023 08:46 by faraweigh2 Just look at the 1 and 5 day OKYO trading summary charts on NASDAQ. Awesome! Read Full Thread Follow Reply
Posted at 18/3/2023 17:18 by spkp313703 Hi why is just a big price difference between Nasdaq and LSE share price 2.75 v/s 1.55? Read Full Thread Follow Reply
Posted at 16/3/2023 11:22 by bibs OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website. "We are excited to be very close now to moving this drug into its first clinical trial and believe that OK-101 can provide a new way to treat DED patients who are presently not well-served by currently approved drugs" said Gary S. Jacob, Ph.D., CEO of OKYO Pharma Ltd. Read Full Thread Follow Reply
Posted at 13/3/2023 15:49 by bibs Okyo CEO states:"2023 is going to be a big year for us!"Shareholder value to be added here... Read Full Thread Follow Reply
Posted at 13/1/2023 11:23 by faraweigh2 Requoted in part from S/T: OKYO Pharma (OKYO): 2.75p Target 7p A problem with the bear market in small caps is that some timelines have been stretched, as well as valuations kept a lid on until companies are much further down the line as far as their milestones. A good example of both delayed market response and depressed share price is dry eye treatment group OKYO. Of course, it may be the case that even after the latest announcement of clearance of its Investigational New Drug (IND) application from the FDA to initiate a Phase 2 human clinical study. What the market has perhaps still not cottoned onto are a few factors here with OKYO. The dry eye treatment market is a multi-billion dollar one, with the jump in technology with OK-101 which is a treatment, rather than current applications which mere address the symptoms of dry eyes in a mechanical way. Just as important is that because OK-101 is a topical treatment it will have accelerated FDA approval, a point underlined by this month’s news from the company. Such an accelerated approved clearly means that the costs of development are that much more economic. Finally, given the way that the market cap is back to where it was two years ago, despite the advances made, we could see a realignment in 2023, especially given the drug will be “moving into the clinic in the first quarter of 2023"? Read Full Thread Follow Reply
Posted at 17/9/2020 15:55 by dodobird25 Thank you for your reply. I am in total agreement, and I too should have sold when the OKYO share price was listed at around 18p. This has proven to be the case with other pharmaceuticals recently (TILS, SNG to mention two). No more FOMO for me - I have proven it to be a loser's game in the main part. From now on, I shall be selling, when a healthy profit has been achieved, and perhaps buying back if there is a significant pullback. I wish you well with your future investments. Your prediction regarding OKYO, when at its recent peak, has been proven to be correct. We should have a clearer indication as to where this share price is heading next week. I see nothing untoward in my research, but several companies, whose retail shareholders were anticipating significant growth following results, have come unstuck recently. Read Full Thread Follow Reply

Okyo Pharma share price data is direct from the London Stock Exchange

Your Recent History

LSE

OKYO

Okyo Pharm..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea

V: D: 20230609 01:15:09